Natixis Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43M | Buy |
708,704
+66,776
| +10% | +$3.89M | 0.06% | 302 |
|
|
2025
Q4 | $34.6M | Buy |
641,928
+51,668
| +9% | +$2.49M | 0.05% | 336 |
|
|
2025
Q3 | $26.6M | Buy |
590,260
+44,698
| +8% | +$2.09M | 0.04% | 398 |
|
|
2025
Q2 | $25.3M | Sell |
545,562
-246,105
| -31% | -$12.1M | 0.04% | 394 |
|
|
2025
Q1 | $48.3M | Buy |
791,667
+110,826
| +16% | +$6.46M | 0.09% | 237 |
|
|
2024
Q4 | $38.5M | Buy |
680,841
+234,477
| +53% | +$13.1M | 0.07% | 272 |
|
|
2024
Q3 | $23.1M | Buy |
446,364
+115,361
| +35% | +$5.41M | 0.05% | 377 |
|
|
2024
Q2 | $13.7M | Sell |
331,003
-288,365
| -47% | -$12.9M | 0.03% | 501 |
|
|
2024
Q1 | $33.6M | Buy |
619,368
+31,147
| +5% | +$1.59M | 0.08% | 266 |
|
|
2023
Q4 | $30.2M | Sell |
588,221
-251,441
| -30% | -$13.2M | 0.08% | 263 |
|
|
2023
Q3 | $48.7M | Sell |
839,662
-135,150
| -14% | -$8.28M | 0.15% | 156 |
|
|
2023
Q2 | $62.3M | Buy |
974,812
+47,253
| +5% | +$3.17M | 0.19% | 128 |
|
|
2023
Q1 | $64.3M | Sell |
927,559
-44,195
| -5% | -$3.12M | 0.22% | 119 |
|
|
2022
Q4 | $69.9M | Sell |
971,754
-22,411
| -2% | -$1.69M | 0.26% | 102 |
|
|
2022
Q3 | $70.7M | Sell |
994,165
-94,666
| -9% | -$6.87M | 0.3% | 82 |
|
|
2022
Q2 | $83.8M | Buy |
1,088,831
+159,481
| +17% | +$12.1M | 0.37% | 65 |
|
|
2022
Q1 | $67.9M | Buy |
929,350
+167,418
| +22% | +$11.2M | 0.26% | 94 |
|
|
2021
Q4 | $47.5M | Buy |
761,932
+67,957
| +10% | +$3.99M | 0.18% | 134 |
|
|
2021
Q3 | $41.1M | Sell |
693,975
-145,531
| -17% | -$9.58M | 0.17% | 143 |
|
|
2021
Q2 | $56.1M | Buy |
839,506
+68,453
| +9% | +$4.46M | 0.26% | 88 |
|
|
2021
Q1 | $48.7M | Buy |
771,053
+42,102
| +6% | +$2.62M | 0.25% | 91 |
|
|
2020
Q4 | $45.2M | Buy |
728,951
+46,444
| +7% | +$2.86M | 0.26% | 81 |
|
|
2020
Q3 | $41.1M | Sell |
682,507
-30,603
| -4% | -$1.84M | 0.26% | 83 |
|
|
2020
Q2 | $41.9M | Buy |
713,110
+80,441
| +13% | +$4.81M | 0.28% | 75 |
|
|
2020
Q1 | $35.3M | Buy |
632,669
+1,836
| +0.3% | +$112K | 0.29% | 76 |
|
|
2019
Q4 | $40.5M | Buy |
630,833
+116,396
| +23% | +$6.67M | 0.29% | 73 |
|
|
2019
Q3 | $26.1M | Buy |
514,437
+237,630
| +86% | +$11.2M | 0.21% | 114 |
|
|
2019
Q2 | $12.6M | Buy |
276,807
+109,365
| +65% | +$5.09M | 0.1% | 222 |
|
|
2019
Q1 | $7.99M | Sell |
167,442
-11,226
| -6% | -$559K | 0.07% | 312 |
|
|
2018
Q4 | $9.29M | Buy |
178,668
+2,997
| +2% | +$161K | 0.09% | 242 |
|
|
2018
Q3 | $10.9M | Buy |
175,671
+9,214
| +6% | +$547K | 0.1% | 236 |
|
|
2018
Q2 | $9.21M | Sell |
166,457
-21,073
| -11% | -$1.14M | 0.09% | 269 |
|
|
2018
Q1 | $11.9M | Buy |
187,530
+17,849
| +11% | +$1.15M | 0.12% | 197 |
|
|
2017
Q4 | $10.4M | Buy |
169,681
+1,322
| +0.8% | +$82.7K | 0.11% | 227 |
|
|
2017
Q3 | $10.7M | Buy |
168,359
+47,888
| +40% | +$2.8M | 0.11% | 209 |
|
|
2017
Q2 | $6.71M | Sell |
120,471
-67,705
| -36% | -$3.68M | 0.07% | 328 |
|
|
2017
Q1 | $10.2M | Sell |
188,176
-123,655
| -40% | -$6.78M | 0.11% | 219 |
|
|
2016
Q4 | $18.2M | Buy |
311,831
+46,215
| +17% | +$2.53M | 0.22% | 104 |
|
|
2016
Q3 | $14.3M | Buy |
265,616
+62,454
| +31% | +$4.01M | 0.19% | 135 |
|
|
2016
Q2 | $14.9M | Buy |
203,162
+76,844
| +61% | +$5.43M | 0.21% | 114 |
|
|
2016
Q1 | $8.07M | Sell |
126,318
-12,785
| -9% | -$806K | 0.12% | 203 |
|
|
2015
Q4 | $9.57M | Sell |
139,103
-3,987
| -3% | -$263K | 0.16% | 160 |
|
|
2015
Q3 | $8.47M | Sell |
143,090
-66,309
| -32% | -$4.21M | 0.15% | 171 |
|
|
2015
Q2 | $13.9M | Buy |
209,399
+1,726
| +0.8% | +$114K | 0.24% | 89 |
|
|
2015
Q1 | $13.4M | Buy |
207,673
+5,539
| +3% | +$347K | 0.24% | 90 |
|
|
2014
Q4 | $11.9M | Sell |
202,134
-7,065
| -3% | -$398K | 0.22% | 92 |
|
|
2014
Q3 | $10.7M | Sell |
209,199
-19,234
| -8% | -$961K | 0.21% | 101 |
|
|
2014
Q2 | $11.1M | Buy |
228,433
+1,649
| +0.7% | +$81.3K | 0.16% | 185 |
|
|
2014
Q1 | $11.8M | Buy |
226,784
+4,921
| +2% | +$262K | 0.18% | 167 |
|
|
2013
Q4 | $11.8M | Buy |
221,863
+40,686
| +22% | +$2.07M | 0.19% | 147 |
|
|
2013
Q3 | $8.38M | Buy |
181,177
+7,963
| +5% | +$350K | 0.15% | 218 |
|
|
2013
Q2 | $7.74M | Buy |
+173,214
| New | +$7.52M | 0.15% | 224 |
|
Other funds holding BMY
VCM
VPM
Natixis Advisors's BMY Position: Q1 2026 in Review
Natixis Advisors increased its Bristol-Myers Squibb (BMY) stake by 10% in Q1 2026, buying an estimated $3.89M and bringing the position to 708,704 shares worth $43M. The position accounts for 0.06% of the portfolio, ranked #302.
Natixis Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $83.8M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Natixis Advisors held 708,704 shares of Bristol-Myers Squibb worth $43M as of Q1 2026.
- Natixis Advisors bought 66,776 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.89M.
- Bristol-Myers Squibb made up 0.06% of Natixis Advisors's portfolio in Q1 2026, its #302 holding.
- Natixis Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Natixis Advisors's Bristol-Myers Squibb position peaked at $83.8M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.